CFCE-DFCI
@cfce_danafarber
The Center for Functional Cancer Epigenetics (CFCE) explores the role that epigenetic alterations play in the development and progression of cancer.
ID: 969580848860291073
http://cfce.dfci.harvard.edu/ 02-03-2018 14:31:03
283 Tweet
304 Followers
104 Following
SO timely! A short teaser preprint from a wonderful collab w/ Alex swarbrick lab. Full protocol available for in supporting material. snPATHO-seq: unlocking the FFPE archives for single nucleus RNA profiling 10x Genomics biorxiv.org/content/10.110…
Our prostate cancer cfDNA methylation profiling study is out Nature Communications, >200 patients, strong classifier for local disease and mets, methylation at GR related to immune signature and outcome. More to be discovered. Dataset available through EGA. rdcu.be/cYwNs
Super cool project from Johannes Köster’s group on making datavzrd = tool to create visual and interactive HTML reports from collections of CSV/TSV tables! #biodata22 🔗 github.com/koesterlab/dat…
New collaboration led by Carlo Palmieri with RCSI School of Pharmacy and Biomolecular Sciences Beaumont RCSI Cancer Centre EORG groups highlighting immune differences between breast cancer and brain mets and the potential importance of ARG2 expression in T-cell depletion and clinical outcome. sciencedirect.com/science/articl…
🕺🏿 OUT TODAY Nature Genetics 📰 Enhancer–promoter interactions and transcription are largely maintained upon acute loss of CTCF, cohesin, WAPL or YY1 🧑🏿🤝🧑🏼 Xavier Darzacq Robert Tjian, and team 👇 go.nature.com/3He5aVy
I am happy to communicate that SCENIC+ was published in Nature Methods. SCENIC+ is a workflow to infer enhancer-driven gene regulatory networks from scRNA-seq and scATAC-seq data. This work was done together with Carmen Bravo at Stein Aerts lab! 🧵1/9🧵 nature.com/articles/s4159…
So sad to say goodbye to Ruiyang who has done such fantastic work over the past year at the Dana-Farber! But we know we will continue to do great things in grad school Columbia University and NY Genome Center.
The Gray Foundation has awarded $25 million to 7 research teams, 5 of which are based in Greater Boston, to fight BRCA-related cancers. "Boston is number one in terms of cancer research,” Laurie Glimcher MD said. “It’s an unbelievable life sciences ecosystem.” bostonglobe.com/2023/08/10/bus…